MMP9 and glioblastoma: This study examined the effect of wild-type human TIMP-1 and TIMP-3 recombinant proteins and the engineered minimal TIMP variant [24] for inhibition of MMP-9 to reduce the migratory and invasive capabilities of GBM cells.